Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 20 CGEN Compugen Ltd. (CGEN) Q1 2024 Earnings Call Transcript
May 20 CGEN Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
May 20 CGEN Compugen GAAP EPS of -$0.08 beats by $0.03, revenue of $2.56M beats by $1.35M
May 20 CGEN Compugen Reports First Quarter 2024 Results
May 18 AUTL Q1 2024 Autolus Therapeutics PLC Earnings Call
May 17 CGEN Compugen Q1 2024 Earnings Preview
May 17 AUTL Autolus Therapeutics plc (AUTL) Q1 2024 Earnings Call Transcript
May 17 AUTL Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
May 17 AUTL Autolus Therapeutics GAAP EPS of -$0.24 misses by $0.09, revenue of $10.09M misses by $14.96M
May 17 AUTL Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
May 17 SEEL Seelos Therapeutics announces pricing of about $1M registered direct offering & concurrent private placement
May 17 SEEL Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
May 16 CRBU Expert Ratings For Caribou Biosciences
May 16 SCNI Scinai Immunotherapeutics reports FY results
May 16 CGEN Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential
May 15 SCNI Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update
May 15 SCPH Q1 2024 scPharmaceuticals Inc Earnings Call
May 15 CGEN Compugen names David Silberman as finance chief
May 15 BCAB BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...
May 15 CGEN Compugen Appoints David Silberman as Chief Financial Officer
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags